Caris Life Sciences Expands Subspecialty Pathology Practice to Urology

IRVING, Texas, April 13, 2010 (GLOBE NEWSWIRE) -- Caris Life Sciences™, a leading biosciences company focused on enabling precise and personalized healthcare, today announced the launch of its urologic pathology practice, available through its subsidiary Caris Diagnostics. The addition of this subspecialty, which is being directed by Rajal B. Shah, M.D., underscores Caris' commitment to providing high quality, academic-caliber diagnostic and theranostic services to a broadening list of subspecialties. Under Dr. Shah's leadership, Caris' urologic pathology experts will also support the development of a revolutionary and proprietary testing platform that will help diagnose and manage prostate cancer patients earlier and less invasively.
MORE ON THIS TOPIC